Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.83 -0.12 (-0.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Price to Earnings (2024 - 2026)

Updated

Aurinia Pharmaceuticals' Price to Earnings came in at 7.18 for Q2 2026, down 61.3% from 18.53 a year earlier but up 10.5% from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) Price to Earnings (2024 - 2026) Analysis & Trends

For FY2025, Aurinia Pharmaceuticals' Price to Earnings was 7.35, down 96.7% from FY2024.

  • Going back by year, Price to Earnings was 219.95 in FY2024.
  • The five-year range for quarterly Price to Earnings is 6.50 (Q1 2026) to 219.95 (Q4 2024).
  • Year-over-year, Price to Earnings has declined for three consecutive quarters.
  • Business Quant data shows AUPH's Price to Earnings at 6.50 (Q1 2026), 7.35 (Q4 2025) and 18.72 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aurinia Pharmaceuticals 2.10 Bn 532.21 Mn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.18
Mar 31, 2026 6.50
Dec 31, 2025 7.35
Sep 30, 2025 18.72
Jun 30, 2025 18.53
Mar 31, 2025 27.79
Dec 31, 2024 219.95
API Access

Aurinia Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=AUPH&period=max&api_key=YOUR_API_KEY